It has been reported that ASF1B, rather than ASF1A, is critical for proliferation and has highly significant prognostic value in breast cancer and cervical cancer (Corpet et al., 2011; Han et al., 2018; Jiangqiao et al., 2019; Liu et al., 2020). Here, ASF1B is linked to breast carcinoma.